ß-blocker therapy is a standard of care for patients after myocardial infarction, with a prescription rate that has reached over 90% in most Western countries. However, early coronary reperfusion therapy has led to a sharp decrease in the risks of heart failure and death after myocardial infarction and has led to questions about the add-on benefits of lifelong b-blocker treatment in patients with a preserved left ventricular ejection fraction and no other primary indication for b-blocker therapy.

Cutaneous adverse reactions are a common occurrence when it comes to antibiotic use, impacting a significant portion of patients. These reactions can range from mild rashes to severe life-threatening conditions such as Stevens-Johnson syndrome.

Corey Diamond, PharmD

Research shows that an infusion of amino acids may help protect patients from acute kidney injury (AKI) following cardiac surgery.

Aiya Almogaber, PharmD

Much has been said about the importance of having pharmacists in an emergency department (ED), but little is out there about what pharmacists are capable of in a freestanding ED.

Loren Bonner

WHO has noted that, upon hospital discharge, as many as 80% of patients may have a medication discrepancy or a health care provider may have failed to communicate an in-hospital medication change. These discrepancies can lead to increased health care costs, hospital readmissions, and patient harm. 

Sonya Collins